Substitutes for success

Nature Medicine

Volumn 5, Issue 1, 1999, Pages 17-18

  Blajchman, Morris A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINOID; BLOOD SUBSTITUTE; FIBRINOGEN; SYNTHOCYTE; THROMBOSPHERE; UNCLASSIFIED DRUG;

BLEEDING; BLOOD SUBSTITUTION; DRUG FORMULATION; DRUG SAFETY; HUMAN; MICROENCAPSULATION; OXYGEN AFFINITY; OXYGEN TRANSPORT; PRIORITY JOURNAL; SHORT SURVEY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ALBUMINS; ANIMALS; BLOOD PLATELETS; BLOOD SUBSTITUTES; CAPSULES; DISEASE MODELS, ANIMAL; FIBRINOGEN; HUMANS; RABBITS; THROMBOCYTOPENIA;

EID: 0032974608     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/4694     Document Type: Short Survey

References (8)

1. Schreiber, G.B. et al. The risk of transfusion-transmitted viral infections. N. Engl. J. Med. 334, 1685-1690 (1996).
2. Chan, K. Blood supply: FDA Oversight and Remaining Issues of Safety. Washington, DC, U.S. General Accounting Office (1997).
3. Levi, M. et al. Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits. Nature Med. 5, 107-111 (1999).
4. Hess, J.R. & Reiss, R. F. Resuscitation and limited utility of the present generation of blood substitutes. Transfus. Med. Rev. 10, 276-285 (1996).
5. Lee, D. & Blajchman, M.A. Novel platelet products and substitutes. Transfus. Med. Rev. 12, 175-187 (1998).
6. Corash, L. Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: Current research perspectives. Transfus. Med. Rev. 13, 18-30 (1999).
7. Alving, B.M. et al. Frozen platelets and platelet substitutes in transfus, medicine. Transfus. 37, 866-877 (1997).
8. Yen, R.C.K., Ho, T.W.C. & Blajchman, M.A. A novel approach to correcting the bleeding associated with thrombocytopenia. Transfus. 35 (supplement) 41S (1995).